Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with respiratory tract.
Factors such as increase in prevalence of respiratory diseases, rise in geriatric population, sedentary lifestyle, high prevalence of smoking, growth in pollution levels, and urbanization drive the market growth. However, reimbursement issues and harmful effects of certain respiratory care devices on neonates restrain the market growth. Moreover, rise in need for home care therapeutic devices and healthcare growth in the developing countries increase opportunities for the market growth.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/4188
The global pulmonary devices market is segmented on the basis of type, disease, end user, and region. On the basis of type, it is segmented into therapeutic devices, consumables & accessories, diagnostic devices, and monitoring devices. By therapeutic devices, it is classified into humidifiers (heated and passover humidifiers), nebulizers, oxygen concentrators (fixed and portable oxygen concentrators), positive airway pressure (PAP) devices (continuous PAP devices, automatic PAP devices, and bi-level PAP devices), reusable resuscitators (adult resuscitators and infant/neonatal resuscitators), ventilators (adult ventilators and neonatal ventilators), inhalers (metered dose inhalers and dry powder inhalers), masks (nasal masks, full-face masks, nasal pillow masks, and oral masks), nitric oxide delivery units, and oxygen hoods.
The consumables and accessories segment is sub segmented into disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas, and others. The diagnostic devices segment is sub segmented into spirometers, polysomnography devices (PSG), peak flow meters, and other diagnostic devices.
The monitoring devices segment is sub segmented into pulse oximeters (pulse oximeter sensors and pulse oximeter equipment), capnographs, and gas analyzers. On the basis of disease, the market is categorized into asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, infectious diseases, and others. On the basis of end-user, it is divided into hospitals, ambulatory care, and home care. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4188
Some of the prominent players in the global market include GlaxoSmithKline plc, 3M Company, Medtronic plc, Koninklijke Philips N.V., ResMed Inc., Masimo Corporation, Thermo Fisher Scientific, Fisher & Paykel Healthcare Limited, Becton, Dickinson and Company, and Hamilton Medical AG.
• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis by product helps understand the various types of devices used for treatment of pulmonary diseases.
• Comprehensive analysis of all geographical regions is provided, which helps determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which elucidates the competitive outlook of the global market.
Access Full Summery @ https://www.alliedmarketresearch.com/pulmonary-devices-market